Gontier, A.; Youala, M.; Fontaine, C.; Raibon, E.; Fournel, S.; Briantais, P.; Rigaut, D.
Efficacy and Safety of 4.7 mg Deslorelin Acetate Implants in Suppressing Oestrus Cycle in Prepubertal Female Dogs. Animals 2022, 12, 3504.
https://doi.org/10.3390/ani12243504
AMA Style
Gontier A, Youala M, Fontaine C, Raibon E, Fournel S, Briantais P, Rigaut D.
Efficacy and Safety of 4.7 mg Deslorelin Acetate Implants in Suppressing Oestrus Cycle in Prepubertal Female Dogs. Animals. 2022; 12(24):3504.
https://doi.org/10.3390/ani12243504
Chicago/Turabian Style
Gontier, Aymeric, Myriam Youala, Christelle Fontaine, Elsa Raibon, Sandrine Fournel, Philippe Briantais, and Delphine Rigaut.
2022. "Efficacy and Safety of 4.7 mg Deslorelin Acetate Implants in Suppressing Oestrus Cycle in Prepubertal Female Dogs" Animals 12, no. 24: 3504.
https://doi.org/10.3390/ani12243504
APA Style
Gontier, A., Youala, M., Fontaine, C., Raibon, E., Fournel, S., Briantais, P., & Rigaut, D.
(2022). Efficacy and Safety of 4.7 mg Deslorelin Acetate Implants in Suppressing Oestrus Cycle in Prepubertal Female Dogs. Animals, 12(24), 3504.
https://doi.org/10.3390/ani12243504